GLP-1 receptor agonists have transformed weight management and type 2 diabetes treatment. Whether you're just starting or already on your journey, understanding how these medications work helps you get the most from them. This guide covers the major GLP-1 medications, their mechanisms, tracking practices that help, and how to get medication-specific answers from your care team.
What Are GLP-1 Receptor Agonists?
GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces in the gut after eating. It signals your brain that you're full, slows stomach emptying, and helps regulate blood sugar by stimulating insulin release when glucose is high. GLP-1 receptor agonists are synthetic versions of this hormone that last much longer in your body — the natural hormone is broken down within minutes, while medications can last a full week.
By mimicking and amplifying your body's natural GLP-1 response, these medications help you feel full sooner, stay satisfied longer, and experience fewer cravings. This is why they're so effective for weight loss — they address the biological drivers of appetite rather than relying on willpower alone.
The Major GLP-1 Medications
Semaglutide (Ozempic & Wegovy)
Ozempic is approved for type 2 diabetes. Wegovy contains the same active ingredient (semaglutide) and is approved for chronic weight management. Both are injectable, delivered via a pre-filled pen, and taken once weekly. The approved strengths and maximum dose differ between the two products and are listed in each product's own prescribing information — your prescriber decides which applies to you.
Semaglutide has been studied extensively in clinical trials. The average results reported in those trials, and the results any one person experiences, are described in the product's prescribing information — they are not a prediction of your own outcome. Your prescriber is the right person to discuss what to expect in your case.
Tirzepatide (Mounjaro & Zepbound)
Mounjaro and Zepbound contain tirzepatide, a newer medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors — a "dual agonist" approach. Acting on two pathways is what distinguishes tirzepatide from single-receptor GLP-1 medications.
Mounjaro is approved for type 2 diabetes; Zepbound is approved for weight management. Both are once-weekly injections. Dose adjustments, if any, are set by your prescriber.
Other GLP-1 Medications
- Rybelsus — The only oral GLP-1 (semaglutide tablet), taken daily on an empty stomach. Lower efficacy than injectable forms but avoids needles.
- Saxenda (liraglutide) — A daily injection approved for weight management. Older generation, lower efficacy (~8% weight loss), but some patients prefer daily dosing.
- Victoza — Same drug as Saxenda (liraglutide) but approved for type 2 diabetes at lower doses.
How GLP-1 Medications Work
GLP-1 receptor agonists work through three primary mechanisms:
- Appetite suppression: They act on receptors in the brain's appetite center (hypothalamus), reducing hunger and increasing feelings of fullness. You eat less without feeling deprived.
- Delayed gastric emptying: They slow the rate at which food leaves your stomach, prolonging fullness after meals. This is also why nausea is a common side effect.
- Blood sugar regulation: They stimulate insulin release when blood sugar is high and suppress glucagon, helping maintain stable glucose levels.
Dose Adjustments Are Prescriber-Led
GLP-1 medications are usually started at a lower dose and adjusted over time, but the starting dose, the timing of any increase, and the maximum dose differ for every medication, every formulation, and every person. They are not interchangeable between products.
This guide deliberately does not list doses or escalation schedules: a number that is correct for one medication or formulation can be wrong — or unsafe — for another. Your prescriber sets your dose, and your own product's official prescribing information contains the approved dosing and instructions for that product.
If you are unsure about your dose, whether to move up, or what to do after a missed dose, ask your prescriber or pharmacist before changing anything.
What Is Useful to Track
You cannot predict your own timeline from someone else's, but you can keep a record that makes your appointments more useful:
- Doses and dates: what you took, when, and at what strength — recorded exactly as prescribed.
- Symptoms and severity: what you felt, when it started, and how long it lasted.
- Hydration and intake: roughly how much you are drinking and eating, especially on days with nausea or low appetite.
- Weight and measurements: the trend across weeks rather than any single reading.
- Questions for your next visit: a running list of side effects and concerns to raise.
Bring that record to your appointments. It helps your prescriber judge whether your current plan is working for you, and it keeps the decisions with them.
Maximizing Your Results
GLP-1 medications are powerful, but they work best as part of a comprehensive approach:
- Prioritize protein: Protein intake is commonly emphasized during weight loss to help preserve muscle. Ask your prescriber or a dietitian what target fits you — it depends on your body weight, kidney health, and other conditions.
- Strength train 2–3x per week: Resistance training signals your body to keep muscle while losing fat. This is critical — GLP-1s reduce appetite for all food, including protein.
- Stay hydrated: GLP-1s increase fullness, which can reduce fluid intake. Sip steadily through the day and ask your prescriber what fluid intake is right for you.
- Track everything: Logging your doses, side effects, meals, and weight gives you and your doctor a complete picture to optimize your treatment.
- Talk before any dose change: If side effects are making it hard to eat or drink, tell your prescriber rather than adjusting the dose yourself.
OptimizeGLP was built specifically for GLP-1 patients — it tracks your injection schedule, logs side effects, calculates your protein targets, and visualizes your progress so you can see exactly how far you've come.
Important Safety Considerations
These medications are not suitable for everyone. The official prescribing information for each product lists its contraindications and warnings — for example, a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) is a contraindication for the semaglutide and tirzepatide products. Those lists differ between medications, so read the warnings for the product you were prescribed rather than relying on a summary.
Contact your prescriber promptly if you have severe or persistent abdominal pain, persistent vomiting, signs of an allergic reaction, or any warning sign listed in your product's information. For an emergency, call 911.
Always consult your prescriber before starting, stopping, or adjusting any medication. This guide is general education and is not a substitute for professional medical advice.
Where to Get Medication-Specific Instructions
Dosing, dose changes, missed doses, storage, injection technique, interactions, and what to do about side effects are all specific to your medication and formulation. Use these sources:
- Your prescriber — for any decision about your dose or treatment plan.
- Your pharmacist — for practical questions about taking, storing, or missing a dose.
- The official prescribing information and Medication Guide for your exact product and strength — published by the manufacturer and available through DailyMed and the FDA's drug databases.
This page is education about tracking and habits. It does not contain your dosing instructions and does not replace the information that came with your prescription.